Company: DMAC
Filing Date: 2025-03-28
Form Type: DEFA14A
Source: 0001437749-25-009698
Chunk: 0

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEFA14A
Chunk 0
---
### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION
<div align='center'>Washington, D.C. 20549

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement                                                      |
| ☒ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-2                    |

| DIAMEDICA THERAPEUTICS INC.                      |
| (Name of Registrant as Specified In Its Charter) |

Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required                                                                                     |
| ☐ | Fee paid previously with preliminary materials                                                      |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |